These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 22751903)

  • 21. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.
    Gallo O; Franchi A; Magnelli L; Sardi I; Vannacci A; Boddi V; Chiarugi V; Masini E
    Neoplasia; 2001; 3(1):53-61. PubMed ID: 11326316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.
    Wang X; Zhang L; O'Neill A; Bahamon B; Alsop DC; Mier JW; Goldberg SN; Signoretti S; Atkins MB; Wood CG; Bhatt RS
    Br J Cancer; 2013 Feb; 108(2):319-26. PubMed ID: 23322198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.
    Zhao Y; Hao Y; Ji H; Fang Y; Guo Y; Sha W; Zhou Y; Pang X; Southerland WM; Califano JA; Gu X
    Cancer Prev Res (Phila); 2010 Jun; 3(6):787-96. PubMed ID: 20501859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PC-407, a celecoxib derivative, inhibited the growth of colorectal tumor in vitro and in vivo.
    Li Y; Niu Y; Wu H; Zhang B; Sun Y; Huang H; Li Q; Fan L; Liu L; Mei Q
    Cancer Sci; 2009 Dec; 100(12):2451-8. PubMed ID: 19814734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo.
    Li W; Jiang HR; Xu XL; Wang J; Zhang J; Liu ML; Zhai LY
    Int J Mol Sci; 2010 Oct; 11(10):3999-4013. PubMed ID: 21152316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of celecoxib pharmacodynamics in pancreatic cancer.
    Jimeno A; Amador ML; Kulesza P; Wang X; Rubio-Viqueira B; Zhang X; Chan A; Wheelhouse J; Kuramochi H; Tanaka K; Danenberg K; Messersmith WA; Almuete V; Hruban RH; Maitra A; Yeo CJ; Hidalgo M
    Mol Cancer Ther; 2006 Dec; 5(12):3240-7. PubMed ID: 17172427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibitory effect of nimesulide and oxaliplatin on tumor growth and lymphatic metastasis of transplanted human lung cancer in nude mice].
    Lang Z; Chen G; Wang DC
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):739-44. PubMed ID: 23291066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of cyclooxygenase-2 suppresses metastatic disease without affecting primary tumor growth in a murine model of Ewing sarcoma.
    Gendy AS; Lipskar A; Glick RD; Steinberg BM; Edelman M; Soffer SZ
    J Pediatr Surg; 2011 Jan; 46(1):108-14. PubMed ID: 21238650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.
    Xu XF; Xie CG; Wang XP; Liu J; Yu YC; Hu HL; Guo CY
    Tohoku J Exp Med; 2008 Jun; 215(2):149-57. PubMed ID: 18577844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tumoral effect of a celecoxib low dose on a model of human medullary thyroid cancer in nude mice.
    Quidville V; Segond N; Tebbi A; Cohen R; Jullienne A; Lepoivre M; Lausson S
    Thyroid; 2009 Jun; 19(6):613-21. PubMed ID: 19281427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.
    Shaik MS; Chatterjee A; Jackson T; Singh M
    Int J Cancer; 2006 Jan; 118(2):396-404. PubMed ID: 16052515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma.
    Zuo C; Qiu X; Liu N; Yang D; Xia M; Liu J; Wang X; Zhu H; Xie H; Dan H; Li Q; Wu Q; Burns M; Liu C
    Exp Cell Res; 2015 May; 333(2):316-326. PubMed ID: 25724899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
    Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
    World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.
    Park W; Oh YT; Han JH; Pyo H
    J Exp Clin Cancer Res; 2008 Nov; 27(1):66. PubMed ID: 19000324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
    Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
    Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer.
    Zhang B; Ma X; Li Z; Gao X; Wang F; Liu L; Shen G; Sang Y; Li M; Li Y; Zhao J; Wei Y
    J Cancer Res Clin Oncol; 2013 May; 139(5):797-807. PubMed ID: 23385883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.